By

Editor

Introducción a la Evaluación Económica de Intervenciones
Sanitarias (Farmacoeconomía)

Octubre 2015. Madrid

Evaluaciones económicas
de medicamentos
en la toma de decisiones
terapéuticas dentro del SNS

Octubre 2015. Madrid

García Dorado M, Quintero J, Gonzalez Martin del Moro B, Cuervo-Arango I, Oyagüez I

 

Cost minimization analysis comparing paliperidone palmitate long-acting inyectable with risperidone long-acting inyectable in Spain
XVIII Congreso Sociedad Española de Psiquiatría (SEP). Santiago de Compostela, España. 24-26 sep 2015

Berlana D, Almendral MA, Abad MR, Fernández A, Torralba A, Cervera M, Piñeiro G, Romero-Jiménez R, Vázquez A, Ramírez E, Marced-Barrachina E, Muñoz A, Torres C

 

Economic assessment in the preparation of parenteral nutrition: Manual compounded bags versus three-chamber bags. Nutripar study
37th European Society For Clinical Nutrition And Metabolism Congress (ESPEN). Lisboa, Portugal. 5-8 sep 2015

Curso en Evaluación Económica de Medicamentos

Septiembre 2015. Madrid

Jiménez-Ruiz CA, Solano-Reina S, Signes-Costa J, de Higes-Martinez E, Granda-Orive JI, Lorza-Blasco JJ, Riesco-Miranda JA, Altet-Gomez N, Barrueco-Ferrero M, Oyagüez I, Rejas J

 

Budgetary Impact Analysis on Funding Smoking-cessation Drugs in Patients with Chronic Obstructive Pulmonary Disease in Spain
Int J Chron Obstruct Pulmon Dis. 2015;10:2027-36

Gros B, Galan A, Gonzalez-Parra E, Herrero JA, Echave M, Vegter S, Tolley K, Oyagüez I

 

 

Cost effectiveness of Lanthanum Carbonate in chronic kidney disease patients in Spain before and during dialysis
Health Econ Rev. 2015;5:14 doi:10.1186/s13561-015-0049-3

Romero-Gómez M, Turnes J, Ampuero J, Oyagüez I, Cuenca B, González-García J, Muñoz-Molina B, Aguilar R, Leal S, Planas R, García-Samaniego J, Diago M, Crespo J, Calleja JL, Casado MA, Solà R

 

Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: The Optim Study
PLoS One.2015;10(3):e0122613.doi:10.1371/journal.pone.0122613

Gros B, Soto J, Casado MA

 

 

 

Incorporation of future costs in health economic analysis publications: Current situation and recommendations for the future
Expert Rev Pharmacoecon Outcomes Res. 2015;15(3):465-9

Mar J, Masjuan J, Oliva-Moreno J, Gonzalez-Rojas N, Becerra V, Casado MA, Torres C, Yebenes M, Quintana M, Alvarez-Sabín J

 

 

Outcomes measured by mortality rates, quality of life and degree of autonomy in the first year in Stroke Units in Spain
Health Qual Life Outcomes. 2015;13:36. doi: 10.1186/s12955-015-0230-8